# Study of TCP-ATRA for Adult Patients With AML and MDS

> **NCT02273102** · PHASE1 · COMPLETED · sponsor: **University of Miami** · enrollment: 17 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Myelodysplastic Syndromes
- Leukemia

## Interventions

- **DRUG:** Tranylcypromine
- **DRUG:** Tretinoin

## Key facts

- **NCT ID:** NCT02273102
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-02
- **Primary completion:** 2018-11-08
- **Final completion:** 2020-07-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-07-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02273102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02273102, "Study of TCP-ATRA for Adult Patients With AML and MDS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02273102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*